{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:46:26Z","timestamp":1777452386972,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ejim.2022.10.009","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T08:25:39Z","timestamp":1666167939000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Community-acquired pneumonia \u2013 An EFIM guideline critical appraisal adaptation for internists"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6638-7955","authenticated-orcid":false,"given":"Ahmet Gorkem","family":"Er","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto Antonio Romero","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2562-4816","authenticated-orcid":false,"given":"Ignacio","family":"Marin-Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Sayiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-1425","authenticated-orcid":false,"given":"Stefano","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kutay","family":"Demirkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Lacor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Lode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiktoria","family":"Lesniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mine Durusu","family":"Tanriover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Fuat","family":"Kalyoncu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00e1s","family":"Merchante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serhat","family":"Unal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10258","key":"10.1016\/j.ejim.2022.10.009_bib0001","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Diseases","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejim.2022.10.009_bib0002","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1183\/09031936.00105513","article-title":"Respiratory health and disease in Europe: the new European Lung White Book","volume":"42","author":"Gibson","year":"2013","journal-title":"Eur Respir J"},{"issue":"13","key":"10.1016\/j.ejim.2022.10.009_bib0003","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/archinte.161.13.1629","article-title":"Risk factors for adverse drug events among nursing home residents","volume":"161","author":"Field","year":"2001","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.ejim.2022.10.009_bib0004","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jgs.14682","article-title":"Clinical Outcomes Associated with Medication Regimen Complexity in Older People: A Systematic Review","volume":"65","author":"Wimmer","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"155","key":"10.1016\/j.ejim.2022.10.009_bib0005","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0126-2019","article-title":"Community-acquired pneumonia in critically ill very old patients: a growing problem","volume":"29","author":"Cilloniz","year":"2020","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ejim.2022.10.009_bib0006","doi-asserted-by":"crossref","unstructured":"T. Nguyen, K, et al., Pneumonia: Drug-Related Problems and Hospital Readmissions, in Pneumonia [Working Title]. 2021.","DOI":"10.5772\/intechopen.100127"},{"key":"10.1016\/j.ejim.2022.10.009_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.05.016","article-title":"Clinical practice guidelines adaptation for internists - An EFIM methodology","volume":"77","author":"Lesniak","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.ejim.2022.10.009_bib0008","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccm.2018.07.006","article-title":"Guidelines to Manage Community-Acquired Pneumonia","volume":"39","author":"Wunderink","year":"2018","journal-title":"Clin Chest Med"},{"issue":"5","key":"10.1016\/j.ejim.2022.10.009_bib0009","doi-asserted-by":"crossref","first-page":"e13478","DOI":"10.1111\/ijcp.13478","article-title":"Clinical practice guidelines for the management of community-acquired pneumonia: A critical appraisal using the AGREE II instrument","volume":"74","author":"Triana","year":"2020","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1016\/j.ejim.2022.10.009_bib0010","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/MCP.0000000000000371","article-title":"Community-acquired pneumonia requiring hospitalization: rational decision making and interpretation of guidelines","volume":"23","author":"Postma","year":"2017","journal-title":"Curr Opin Pulm Med"},{"issue":"18","key":"10.1016\/j.ejim.2022.10.009_bib0011","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"issue":"Suppl 3","key":"10.1016\/j.ejim.2022.10.009_bib0012","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1136\/thx.2009.121434","article-title":"BTS guidelines for the management of community acquired pneumonia in adults: update 2009","volume":"64","author":"Lim","year":"2009","journal-title":"Thorax"},{"issue":"Suppl 6","key":"10.1016\/j.ejim.2022.10.009_bib0013","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections\u2013full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.ejim.2022.10.009_bib0014","first-page":"4","article-title":"Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT)","volume":"76","author":"Wiersinga","year":"2018","journal-title":"Neth J Med"},{"issue":"7","key":"10.1016\/j.ejim.2022.10.009_bib0015","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2022.10.009_bib0016","unstructured":"National Institute for Health and Care Excellence (NICE). Pneumonia (community-acquired): antimicrobial prescribing [NG138]. 2019 13\/02\/2021]; Available from: https:\/\/www.nice.org.uk\/guidance\/ng138."},{"issue":"2","key":"10.1016\/j.ejim.2022.10.009_bib0017","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3947\/ic.2018.50.2.160","article-title":"Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia","volume":"50","author":"Lee","year":"2018","journal-title":"Infect Chemother"},{"key":"10.1016\/j.ejim.2022.10.009_bib0018","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejim.2021.12.001","article-title":"Pulmonary embolism - An EFIM guideline critical appraisal and adaptation for practicing clinicians","volume":"96","author":"Becattini","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"7454","key":"10.1016\/j.ejim.2022.10.009_bib0019","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ejim.2022.10.009_bib0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejim.2022.10.009_bib0021","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.ejim.2022.10.009_bib0022","first-page":"502","article-title":"Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the Netherlands","volume":"71","author":"Huijts","year":"2013","journal-title":"Neth J Med"},{"issue":"10","key":"10.1016\/j.ejim.2022.10.009_bib0023","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1445-5994.2012.02880.x","article-title":"Clarithromycin for community-acquired pneumonia: beware drug interactions","volume":"42","author":"Bayles","year":"2012","journal-title":"Intern Med J"},{"issue":"4","key":"10.1016\/j.ejim.2022.10.009_bib0024","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1592\/phco.31.4.408","article-title":"Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations","volume":"31","author":"Miller","year":"2011","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.ejim.2022.10.009_bib0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjmed.2011.08.014","article-title":"Concurrent Use of Warfarin and Antibiotics and the Risk of Bleeding in Older Adults","volume":"125","author":"Baillargeon","year":"2012","journal-title":"The American Journal of Medicine"},{"issue":"2","key":"10.1016\/j.ejim.2022.10.009_bib0026","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/j.1875-9114.1996.tb02949.x","article-title":"Possible role of the intestinal P-450 enzyme system in a cyclosporine-clarithromycin interaction","volume":"16","author":"Sketris","year":"1996","journal-title":"Pharmacotherapy"},{"issue":"10","key":"10.1016\/j.ejim.2022.10.009_bib0027","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/jamainternmed.2014.3293","article-title":"Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas","volume":"174","author":"Parekh","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2022.10.009_bib0028","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.det.2008.07.011","article-title":"Oral antibiotic drug interactions of clinical significance to dermatologists","volume":"27","author":"Del Rosso","year":"2009","journal-title":"Dermatol Clin"},{"issue":"5","key":"10.1016\/j.ejim.2022.10.009_bib0029","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2706","article-title":"The Use of Systemic and Topical Fluoroquinolones","volume":"138","author":"Jackson","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejim.2022.10.009_bib0030","unstructured":"Drugs.com. Drug Interactions Checker. 2021 May 14, 2021]; Available from: https:\/\/www.drugs.com\/drug_interactions.html."},{"key":"10.1016\/j.ejim.2022.10.009_bib0031","unstructured":"IBM Micromedex Medication Management. 2021 May 14, 2021]; Available from: https:\/\/www.ibm.com\/products\/micromedex-with-watson."},{"key":"10.1016\/j.ejim.2022.10.009_bib0032","unstructured":"Lexicomp. 2021 May 14, 2021]; Available from: https:\/\/www.wolterskluwercdi.com\/lexicomp-online\/user-guide\/tools-interactions."},{"key":"10.1016\/j.ejim.2022.10.009_bib0033","unstructured":"Medscape. 2021 May 14, 2021]; Available from: https:\/\/reference.medscape.com\/drug-interactionchecker."},{"issue":"5","key":"10.1016\/j.ejim.2022.10.009_bib0034","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/01.mjt.0000183719.84390.4d","article-title":"Pharmacokinetic-pharmacodynamic crisis in the elderly","volume":"14","author":"ElDesoky","year":"2007","journal-title":"Am J Ther"},{"issue":"11","key":"10.1016\/j.ejim.2022.10.009_bib0035","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/375078","article-title":"Fluoroquinolone-associated tendinopathy: a critical review of the literature","volume":"36","author":"Khaliq","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2022.10.009_bib0036","article-title":"Efficacy of Doxycycline for Mild-to-moderate Community-acquired Pneumonia in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials","author":"Choi","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ejim.2022.10.009_bib0037","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1590\/S1984-82502011000100004","article-title":"Environmental contamination by fluoroquinolones","volume":"50","author":"Frade","year":"2014","journal-title":"Brazilian Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.ejim.2022.10.009_bib0038","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12890-020-1115-0","article-title":"Determinants of empirical antipseudomonal antibiotic prescription for adults with pneumonia in the emergency department","volume":"20","author":"Angrill","year":"2020","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ejim.2022.10.009_bib0039","series-title":"Pneumonia in adults: diagnosis and management","year":"2014"},{"key":"10.1016\/j.ejim.2022.10.009_bib0040","series-title":"COVID-19 rapid guideline: managing COVID-19 [NG191","year":"2021"},{"key":"10.1016\/j.ejim.2022.10.009_bib0041","series-title":"S3-Leitlinie - Empfehlungen zur station\u00e4ren Therapie von Patienten mit COVID-19","year":"2022"},{"key":"10.1016\/j.ejim.2022.10.009_bib0042","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejim.2022.04.002","article-title":"Experience with procalcitonin use during the COVID-19 pandemic","volume":"102","author":"Gonzalez","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.ejim.2022.10.009_bib0043","doi-asserted-by":"crossref","first-page":"dlab133","DOI":"10.1093\/jacamr\/dlab133","article-title":"Evaluation of procalcitonin-guided antimicrobial stewardship in patients admitted to hospital with COVID-19 pneumonia","volume":"3","author":"Calderon","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.ejim.2022.10.009_bib0044","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijid.2022.03.003","article-title":"Bacterial co-infection at hospital admission in patients with COVID-19","volume":"118","author":"Moreno-Garcia","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.ejim.2022.10.009_bib0045","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jinf.2022.06.024","article-title":"Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients","volume":"85","author":"Carbonell","year":"2022","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.ejim.2022.10.009_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262342","article-title":"Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study","volume":"17","author":"Atallah","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2022.10.009_bib0047","doi-asserted-by":"crossref","first-page":"n2132","DOI":"10.1136\/bmj.n2132","article-title":"Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care: pragmatic cluster randomised trial","volume":"374","author":"Lhopitallier","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ejim.2022.10.009_bib0048","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2014-0456","article-title":"Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia","volume":"53","author":"Zhydkov","year":"2015","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"key":"10.1016\/j.ejim.2022.10.009_bib0049","doi-asserted-by":"crossref","first-page":"w20094","DOI":"10.4414\/smw.2019.20094","article-title":"Patterns of multimorbidity in internal medicine patients in Swiss university hospitals: a multicentre cohort study","volume":"149","author":"Aubert","year":"2019","journal-title":"Swiss Med Wkly"},{"issue":"4","key":"10.1016\/j.ejim.2022.10.009_bib0050","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11739-019-02243-9","article-title":"Prevalence and clinical impact of VIral Respiratory tract infections in patients hospitalized for Community-Acquired Pneumonia: the VIRCAP study","volume":"15","author":"Tatarelli","year":"2019","journal-title":"Internal and Emergency Medicine"},{"issue":"7","key":"10.1016\/j.ejim.2022.10.009_bib0051","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40266-018-0554-2","article-title":"International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action","volume":"35","author":"Mangin","year":"2018","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.ejim.2022.10.009_bib0052","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40360-019-0325-7","article-title":"Potential drug-drug interactions among pneumonia patients: do these matter in clinical perspectives?","volume":"20","author":"Noor","year":"2019","journal-title":"BMC Pharmacol Toxicol"},{"issue":"6","key":"10.1016\/j.ejim.2022.10.009_bib0053","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/00002512-199404060-00002","article-title":"Polypharmacy in the aged. Practical solutions","volume":"4","author":"Stewart","year":"1994","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejim.2022.10.009_bib0054","unstructured":"American College of Physicians. Subspecialties of Internal Medicine. September 7, 2021; Available from: https:\/\/www.acponline.org\/about-acp\/about-internal-medicine\/subspecialties-of-internal-medicine."}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522003612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522003612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:37:28Z","timestamp":1760607448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620522003612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":54,"alternative-id":["S0953620522003612"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2022.10.009","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Community-acquired pneumonia \u2013 An EFIM guideline critical appraisal adaptation for internists","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2022.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}